Shares of Moderna Inc. /zigman2/quotes/205619834/composite MRNA -4.45% took a -12% dive 11.87% to $310.61 Wednesday, on what proved to be an all-around poor trading session for the stock market, with the NASDAQ Composite Index /zigman2/quotes/210598365/realtime COMP -2.72% falling 1.83% to 15,254.05 and Dow Jones Industrial Average /zigman2/quotes/210598065/realtime DJIA -1.30% falling 1.34% to 34,022.04. This was the stock's second consecutive day of losses. Moderna Inc. closed $186.88 short of its 52-week high ($497.49), which the company reached on August 10th.
The stock underperformed when compared to some of its competitors Wednesday, as AbbVie Inc. /zigman2/quotes/202428675/composite ABBV -0.79% rose 0.55% to $115.91, Amgen Inc. /zigman2/quotes/209157011/composite AMGN -0.52% rose 0.97% to $200.80, and AstraZeneca PLC ADR /zigman2/quotes/200304487/composite AZN -1.78% rose 0.09% to $54.88. Trading volume (21.3 M) eclipsed its 50-day average volume of 13.1 M.